Enhancement of hepatic parenchyma, aorta, and portal vein in helical CT: Comparison of iodixanol and iopromide

American Journal of Roentgenology

Volumn 168, Issue 1, 1997, Pages 213-217

  Graf, Oswald ^a,b   Scott Gazelle, G ^b   Kreuzer, Soeren ^a   Halpern, Elkan F ^b   Boehm, Patrizia ^a   Lechner, Gerhard ^a   Mueller, Peter R ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMERIC NONIONIC CONTRAST MEDIUM; IODIXANOL; IOPROMIDE; MONOMERIC NONIONIC CONTRAST MEDIUM;

ADULT; AGED; AORTA; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE QUALITY; INTRAVENOUS DRUG ADMINISTRATION; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; OSMOLALITY; PORTAL VEIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 1842412551     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.168.1.8976948     Document Type: Article

References (13)

1. Chambers TP, Baron RL, Lush RM. Hepatic CT enhancement: comparison of ionic and nonionic contrast agents in the same patients. Radiology 1994;190:721-725
2. Nelson RC, Chezmar JL, Peterson JE, Bernardino ME. Contrast-enhanced CT of the liver and spleen: comparison of ionic and nonionic contrast agents. AJR 1989;153:973-976
3. Nelson RC, Moyers JH, Chezmar JL, et al. Hepatic dynamic sequential CT: section enhancement profiles with a bolus of ionic and nonionic contrast agents. Radiology 1991;178:499-502
4. Katayama H, Yamaguchi K, Kozuka T, Taka- shima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media: a report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990;175:621-628
5. Kinnison ML, Powe NR, Steinberg EP. Results of randomized controlled trials of low- versus high-osmolality contrast media. Radiology 1989; 170:381-389
6. Moore RM, Steinberg EP, Powe NR, et al. Frequency and determinants of adverse reactions induced by high-osmolality contrast media. Radiology 1989;170:727-732
7. Wolf GL, Arenson RL, Cross AP. A prospective trial of ionic vs nonionic contrast agents in routine clinical practice. AJR 1989;152:939-944
8. Dawson P, Blomley MJ, Opacifkation of blood vessels and soft tissues at CT with nonionic contrast media. Radiology 1994;193:284-285
9. Dawson P, Blomley MJ. Pharmacokinetic and physiologic basis of contrast enhancement in CT and MR imaging: mathematical model (abstr). Radiology 1995;197(P):347
10. Garcia PA, Bonaldi VM, Bret PM, Liang L, Reinhold C, Atri M. Effect of rate of contrast medium on hepatic enhancement. Radiology 1996;199:185-189
11. Dodd CD, Baron RL. Investigation of contrast enhancement in CT of the liver: the need for improved methods (commentary). AJR 1994; 160;643-646
12. Baron RL. Understanding and optimizing use of contrast material for CT of the liver. AJR 1994; 163:323-331
13. Gazelle G, Wolf GL, McIntire GL, et al. Nano- particulate computed tomography contrast agents for blood pool and liver spleen imaging. Acad Radiol 1994;1:373-376